Detalhe da pesquisa
1.
Special Considerations for Healthy Lifestyle Promotion Across the Life Span in Clinical Settings: A Science Advisory From the American Heart Association.
Circulation;
144(24): e515-e532, 2021 12 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34689570
2.
Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.
Circulation;
144(24): e495-e514, 2021 12 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34689589
3.
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
Vasc Med;
23(3): 232-240, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29600737
4.
Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential.
Curr Atheroscler Rep;
19(3): 12, 2017 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28210974
5.
Using Mobile Health (mHealth) Technology in the Management of Diabetes Mellitus, Physical Inactivity, and Smoking.
Curr Atheroscler Rep;
19(4): 16, 2017 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28243807
6.
Gemfibrozil in Combination with Statins-Is It Really Contraindicated?
Curr Atheroscler Rep;
18(4): 18, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26932225
7.
Highlights of the American College of Cardiology Annual Scientific Sessions 2019.
Circulation;
139(24): 2793-2795, 2019 06 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31180744
8.
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial.
Circulation;
139(3): 410-412, 2019 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30586689
9.
What the guidelines do not say: statin non-benefit groups.
Curr Atheroscler Rep;
17(1): 468, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25404095
10.
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs.
Circulation;
135(25): 2572-2574, 2017 06 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28465286
11.
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Circulation;
134(21): e468-e495, 2016 11 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27754879
12.
Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-4.
Prev Med Rep;
25: 101650, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35127346
13.
Association of Smokeless Tobacco Use With the Use of Other Illicit Drugs in the United States.
Am J Med;
134(1): e15-e19, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32621908
14.
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.
JAMA Netw Open;
4(10): e2128817, 2021 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34709388
15.
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.
J Am Coll Cardiol;
74(15): 1926-1942, 2019 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31601373
16.
Relationship Between Pregnancy Complications and Subsequent Coronary Artery Disease Assessed by Coronary Computed Tomographic Angiography in Black Women.
Circ Cardiovasc Imaging;
12(7): e008754, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31303028
17.
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Circ Cardiovasc Qual Outcomes;
11(5): e004652, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29748356
18.
A Clinician's Guide for Trending Cardiovascular Nutrition Controversies: Part II.
J Am Coll Cardiol;
72(5): 553-568, 2018 07 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30049315
19.
Lipoprotein(a) and LDL-C: The Relevance of Equivalence.
J Am Coll Cardiol;
80(21): 2011-2013, 2022 11 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36396202
20.
JCL roundtable: Future of the lipid laboratory: Using the laboratory to manage the patient (part 2).
J Clin Lipidol;
11(4): 846-854, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28642100